СЕПСИС-АССОЦИИРОВАННАЯ ЭНЦЕФАЛОПАТИЯ У ПАЦИЕНТОВ В КРИТИЧЕСКИХ СОСТОЯНИЯХ
Аннотация
В данном обзоре литературы представлена актуальная информация об энцефалопатии, ассоциированной с сепсисом, у пациентов реанимационного профиля. В обзоре изложены современные представления об этиологии, патогенезе и клиническом течении данной патологии. Определена ведущая роль кишечной микробиоты и ее метаболитов в повреждении гематоэнцефалического барьера при сепсис-ассоциированной энцефалопатии. Отражена проблема специфических методов диагностики и лечения.
Литература
Savvina IA, Beloborodova NV, Trofimova TN. Sepsis-associated encephalopathy: clinical, metabolic, neurophysiological and neuroimaging parallels. New York: Nova Science Publishers; 2023. 294 р. (Neurology – Laboratory and Clinical Research Developments). https://doi.org/10.52305/QQGR0434.
Beloborodova NV, Ostrova IV. Sepsis-associated encephalopathy (review). General Reanimatology. 2017;13(5):121-139. https://doi.org/10.15360/1813-9779-2017-5-121-139. https://www.elibrary.ru/uoixqg. (Russian).
Fesenko OV, Sinopalnikov AI, Filatov VV, Danishevsky SV, Styrt EA. Clinical aspects of septic encephalopathy. Clinical medicine. 2016;94(1):67-70. https://doi.org/10.18821/0023-2149-2016-94-1-67-70. https://www.elibrary.ru/vkyayp. (Russian).
Luo Y, Xu D, Yu C. Research progress on sepsis-associated encephalopathy by inhibiting pyroptosis. Gene. 2025;961:149560. https://doi.org/10.1016/j.gene.2025.149560.
Savvina IA, Zabrodskaya YuM, Sebelev KI, Petrova AO, Bodareva NV, Novikov VYu, Rutkovskiy RV, Rasputina DA. Septic encephalopathy: pathophysiology, pathomorphology, clinical syndromes, treatment tactics. Neurosurgery and Neurology of Childhood. 2017;4(54):20-33. edn: YREWSP. (Russian).
Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L, Barbier F, Goldgran-Toledano D, Marcotte G, Dumenil AS, Jamali S, Lacave G, Ruckly S, Mourvillier B, Timsit JF. Potentially modifiable factors contributing to sepsis-associated encephalopathy. Intensive Care Med. 2017;43(8):1075-1084. https://doi.org/10.1007/s00134-017-4807-z.
Han Y, Xie X, Qiu J, Tang Y, Song Z, Li W, Wu X. Early prediction of sepsis associated encephalopathy in elderly ICU patients using machine learning models: a retrospective study based on the MIMIC-IV database. Front Cell Infect Microbiol. 2025;15:1545979. https://doi.org/10.3389/fcimb.2025.1545979.
Li Y, Yu J, Zeng Z, Lin W. Regulation of ubiquitination in sepsis: from PAMP versus DAMP to peripheral inflammation and cell death. Front Immunol. 2024;15:1513206. https://doi.org/10.3389/fimmu.2024.1513206.
Wang X, Wen X, Yuan S, Zhang J. Gut-brain axis in the pathogenesis of sepsis-associated encephalopathy. Neurobiol Dis. 2024;195:106499. https://doi.org/10.1016/j.nbd.2024.106499.
Li Z, Zhang F, Sun M, Liu J, Zhao L, Liu S, Li S, Wang B. The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy. PeerJ. 2023;11:e15122. https://doi.org/10.7717/peerj.15122.
Zhang Q, Lu C, Fan W, Yin Y. Exploring the molecular mechanism of sepsis-associated encephalopathy by integrated analysis of multiple datasets. Cytokine. 2024;180:156609. https://doi.org/10.1016/j.cyto.2024.156609.
Fei Y, Hao Z, Zheng X, Ji X, Zhao W. Microbiological and clinical predictors of sepsis-associated encephalopathy in bloodstream infections: a retrospective cohort study. Front Cell Infect Microbiol. 2025;15:1548370. https://doi.org/10.3389/fcimb.2025.1548370.
Belyshev SJu. Septicheskaja jencefalopatija: aspekty patogeneza i faktory riska razvitija [master's thesis]. Ekaterinburg (Russian); 2010. 104 р. (Russian).
Sonneville R, Benghanem S, Jeantin L, de Montmollin E, Doman M, Gaudemer A, Thy M, Timsit JF. The spectrum of sepsis-associated encephalopathy: a clinical perspective. Crit Care. 2023;27(1):386. https://doi.org/10.1186/s13054-023-04655-8.
Wang P, Yan J, Shi Q, Yang F, Li X, Shen Y, Liu H, Xie K, Zhao L. Relationship between Nonhepatic Serum Ammonia Levels and Sepsis-Associated Encephalopathy: A Retrospective Cohort Study. Emerg Med Int. 2023;2023:6676033. https://doi.org/10.1155/2023/6676033.
Peng H, Liang Z, Zhang S, Yang Y. Optimal target mean arterial pressure for patients with sepsis-associated encephalopathy: a retrospective cohort study. BMC Infect Dis. 2024;24(1):902. https://doi.org/10.1186/s12879-024-09789-w.
Luo Y, Yang H, Zhou M, Yang W, Zhang W, Li QQ. Elevated Intracranial Pressure Level Is a Risk Factor for Sepsis-associated Encephalopathy: A Prospective Cohort Study. In Vivo. 2023;37(6):2585-2596. https://doi.org/10.21873/invivo.13366.
Struk JuV, Kuznecov SV, Jakusheva OA. Principy intensivnoj terapii i transportirovki bolnyh s ostrym povrezhdeniem golovnogo mozga. Voronezh: VGMU; 2015. 30 р. (Russian).
Bykova KM, Savvina I, Bodareva NV, Zabrodskaya YuM. Pathophysiological aspects and complex diagnosis of sepsis-associated encephalopathy. Prospects for etiopathogenetic therapy. Russian Journal of Anesthesiology and Reanimatology. 2022;4:92-98. https://doi.org/10.17116/anaesthesiology202204192. https://www.elibrary.ru/rykdgq. (Russian).
Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review. Crit Care. 2022;26(1):14. https://doi.org/10.1186/s13054-021-03862-5.
Savvina IA, Dryagina NV, Bykova KM, Iablonskikh DD, Rodchenko AM, Rutkovskiy RV, Matakaeva ZHA, Kasherininov IYU, Mazurok VA, Shlyakhto EV. Biomarkers of acute cerebral damage in complex diagnosis of sepsis-associated encephalopathy. Russian Journal of Anesthesiology and Reanimatology. 2025;3:6‑13. https://doi.org/10.17116/anaesthesiology20250316. https://www.elibrary.ru/zoavkg. (Russian).
Yu D, Liu J, Song X, Ao Y, Li X, Han Y. Analysis of the inflammatory storm response and heparin binding protein levels for the diagnosis and prognosis of sepsis-associated encephalopathy. Eur J Med Res. 2025;30(1):116. https://doi.org/10.1186/s40001-025-02369-x.
Li XL, Xie JF, Ye XY, Li Y, Li YG, Feng K, Tian SM, Lou JH, Xia CD. Value of cerebral hypoxic-ischemic injury markers in the early diagnosis of sepsis associated encephalopathy in burn patients with sepsis. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022;38(1):21-28. https://doi.org/10.3760/cma.j.cn501120-20211006-00346.
Rezepov NA, Skripkin YuV, Ulitkina ON, Grebenchikov OA, Likhvantsev VV. Predictors of the severity of the course and duration of treatment of sepsis-associated delirium. General Resuscitation. 2017;13(6):28-37. https://doi.org/10.15360/1813-9779-2017-6-28-37. https://www.elibrary.ru/zxoxyp. (Russian).
Trembach AV, Bgane NM, Trembach IA, Mironov PI, Aleksandrovich YS. Comparative assessment of the prognostic ability of the organ dysfunction scales pediatric Sequential Organ Failure Assessment (pSOFA), pediatric logistic organ dysfunction 2 (PELOD 2) and the Vasoactive-Inotropic Score (VIS) assessment system in children with septic shock: a retrospective observational study. Аnnals of critical care. 2024;1(1):94-101. https://doi.org/10.21320/1818-474X-2024-1-94-101. https://www.elibrary.ru/otstli. (Russian).
Mei J, Zhang X, Sun X, Hu L, Song Y. Optimizing the prediction of sepsis-associated encephalopathy with cerebral circulation time utilizing a nomogram: a pilot study in the intensive care unit. Front Neurol. 2024;14:1303075. https://doi.org/10.3389/fneur.2023.1303075.
Sharipova VKh, Lutfillaev OK, Berdiev NF. Modern view on the problem of sepsis-associirovannoj encephalopathy in the conditions of the intensive care unit. Oriental Renaissance: Innovative, Educational, Natural and Social Sciences. 2021;1(10):907-931. (Russian).
Rhalib SM, Sviridov SV, Vedenina IV, Nekrasova VS. The sepsis-induced encephalopathy. Russian medical journal. 2018;24(2):99-103. https://doi.org/10.18821/0869-2106-2018-24-2-99-103. https://www.elibrary.ru/xwburf. (Russian).
Bykova KM, Zharova EN, Kasherininov IYu, Matakaeva ZHA, Marichev AO, Savvina IA. Clinical significance of multimodal evoked potentials in patients with septic encephalopathy. Russian Journal of Anesthesiology and Reanimatology. 2023;6:43‑51. https://doi.org/10.17116/anaesthesiology202306143. https://www.elibrary.ru/ckuqle. (Russian).
Wang J, Yang M, Xu H, Huang C, Xia Z, Cheng Y, Shu X, Li Y, Shi B, Qin C, Xiao S, Liu M, Tang W. Diagnostic value of ONSD in sepsis associated encephalopathy of New Zealand rabbits. Brain Res Bull. 2022;179:68-73. https://doi.org/10.1016/j.brainresbull.2021.12.002.
Shen Q, Yu Q, Chen T, Zhang L. Rosuvastatin mitigates blood-brain barrier disruption in sepsis-associated encephalopathy by restoring occludin levels. Eur J Med Res. 2025;30(1):103. https://doi.org/10.1186/s40001-025-02314-y.
Isajkin AI, Chernyshova EA, Jahno NN. Primenenie nejroprotektivnoj terapii pri insultah i cherepno-mozgovoj travme. Trudnyj pacient. 2012;10(11):18-21. edn: PXHQMB. (Russian).
Savvina IA, Blinov SA, Rutkovskij RV, Malhozova AM, Blinova OV, inventors; Savvina IA, Blinov SA, Rutkovskij RV, Malhozova AM, Blinova OV, assignee. Sposob korrekcii kognitivnyh rasstrojstv u reanimacionnyh bolnyh s septicheskoj jencefalopatiej. Russian Federation patent RU 2695355. 2019 July 23. (Russian).
Huang F, Yi J, Zhou T, Gong X. Early acetaminophen use is associated with the reduced mortality risk in patients with sepsis-associated encephalopathy: a retrospective study. Eur J Med Res. 2025;30(1):512. https://doi.org/10.1186/s40001-025-02786-y.
Ružičić A, Srdić T, Bobić K, Drakulić D, Veljković F, Todorović A, Đurašević S, Lakić I. Region-specific neuroprotective effects of meldonium pretreatment in two models of sepsis-associated encephalopathy. Front Pharmacol. 2025;16:1588831. https://doi.org/10.3389/fphar.2025.1588831.
Krzyzaniak K, Krion R, Szymczyk A, Stepniewska E, Sieminski M. Exploring Neuroprotective Agents for Sepsis-Associated Encephalopathy: A Comprehensive Review. Int J Mol Sci. 2023;24(13):10780. https://doi.org/10.3390/ijms241310780.
Tauber SC, Nau R. Treatment of septic encephalopathy and encephalitis - a critical appraisal. Expert Rev Neurother. 2023;23(12):1069-1080. https://doi.org/10.1080/14737175.2023.2288652.
Zorina VN, Bespalov AY, Krasnov KA, Melekhova AS, Reinuk VL. Prospects for the development of new prolonged forms of valproic acid derivatives for the relief of convulsive syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(7):14-19. https://doi.org/10.17116/jnevro202212207114. https://www.elibrary.ru/hlbpjw. (Russian).
Xu M, Wang J, Shi J, Wu X, Zhao Q, Shen H, Chen J, Yu J. Esketamine mitigates endotoxin-induced hippocampal injury by regulating calcium transient and synaptic plasticity via the NF-α1/CREB pathway. Neuropharmacology. 2025;269:110362. https://doi.org/10.1016/j.neuropharm.2025.110362.
Barkhatova NA. Method nonspecific anticytokine therapy of generalized forms of surgical infections. International Research Journal. 2014;4-4(23):12-13. edn: SDBVQZ. (Russian).
Wen Q, Ding Q, Wang J, Yin Y, Xu S, Ju Y, Ji H, Liu B. Cortistatin-14 Exerts Neuroprotective Effect Against Microglial Activation, Blood-brain Barrier Disruption, and Cognitive Impairment in Sepsis-associated Encephalopathy. J Immunol Res. 2022;2022:3334145. https://doi.org/10.1155/2022/3334145.
Sieminski M, Szaruta-Raflesz K, Szypenbejl J, Krzyzaniak K. Potential Neuroprotective Role of Melatonin in Sepsis-Associated Encephalopathy Due to Its Scavenging and Anti-Oxidative Properties. Antioxidants (Basel). 2023;12(9):1786. https://doi.org/10.3390/antiox12091786.
Xie K, Zhang Y, Wang Y, Meng X, Wang Y, Yu Y, Chen H. Hydrogen attenuates sepsis-associated encephalopathy by NRF2 mediated NLRP3 pathway inactivation. Inflamm Res. 2020;69(7):697-710. https://doi.org/10.1007/s00011-020-01347-9.
Zhong H, Liu T, Shang Y, Huang C, Pan S. Breaking the vicious cycle: Targeting the NLRP3 inflammasome for treating sepsis-associated encephalopathy. Biomed Pharmacother. 2024;177:117042. https://doi.org/10.1016/j.biopha.2024.117042.
Zhong X, Xie L, Yang X, Liang F, Yang Y, Tong J, Zhong Y, Zhao K, Tang Y, Yuan C. Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome. Mol Med. 2020;26(1):55. https://doi.org/10.1186/s10020-020-00181-3.
Li Y, Wang F, Luo Y. Ginsenoside Rg1 protects against sepsis-associated encephalopathy through beclin 1-independent autophagy in mice. J Surg Res. 2017;207:181-189. https://doi.org/10.1016/j.jss.2016.08.080.
Sui DM, Xie Q, Yi WJ, Gupta S, Yu XY, Li JB, Wang J, Wang JF, Deng XM. Resveratrol Protects against Sepsis-Associated Encephalopathy and Inhibits the NLRP3/IL-1β Axis in Microglia. Mediators Inflamm. 2016;2016:1045657. https://doi.org/10.1155/2016/1045657.
Xu XE, Li MZ, Yao ES, Gong S, Xie J, Gao W, Xie ZX, Li ZF, Bai XJ, Liu L, Liu XH. Morin exerts protective effects on encephalopathy and sepsis-associated cognitive functions in a murine sepsis model. Brain Res Bull. 2020;159:53-60. https://doi.org/10.1016/j.brainresbull.2020.03.019.
Ferreira FM, Gomes SV, Carvalho LCF, de Alcantara AC, da Cruz Castro ML, Perucci LO, Pio S, Talvani A, de Abreu Vieira PM, Calsavara AJC, Costa DC. Potential of piperine for neuroprotection in sepsis-associated encephalopathy. Life Sci. 2024;337:122353. https://doi.org/10.1016/j.lfs.2023.122353.
Yang YS, Liu CY, Pei MQ, Sun ZD, Lin S, He HF. Quercetin protects against sepsis-associated encephalopathy by inhibiting microglia-neuron crosstalk via the CXCL2/CXCR2 signaling pathway. Phytomedicine. 2024;134:155987. https://doi.org/10.1016/j.phymed.2024.155987.
Tauber SC, Djukic M, Gossner J, Eiffert H, Brück W, Nau R. Sepsis-associated encephalopathy and septic encephalitis: an update. Expert Rev Anti Infect Ther. 2021;19(2):215-231. https://doi.org/10.1080/14787210.2020.1812384.
Kobeliatsky YuYu, Maltseva LA, Mosentsev MF, Lisnycha VM. Glutoxim as a modulator of glutathione redox state in septic patientswith encephalopathy. Medicina neotlozhnyh sostojanij. 2018;4(91):104-109. https://doi.org/10.22141/2224-0586.4.91.2018.137866. https://www.elibrary.ru/xviwix. (Russian).
Bhadauriya MS, Singh H, Suri M, Hanifa M, Bali A. JAK/STAT inhibitors mitigate sepsis-associated cerebral and cognitive injury. Fundam Clin Pharmacol. 2025;39(3):e70005. https://doi.org/10.1111/fcp.70005.
Esen F, Ozcan PE, Tuzun E, Boone MD. Mechanisms of action of intravenous immunoglobulin in septic encephalopathy. Rev Neurosci. 2018;29(4):417-423. https://doi.org/10.1515/revneuro-2017-0065.
Xiao S, Li J, Zhu Q, Pu Y, Hao J, Gong H. Relationship between antibiotic use and short-term risk of mortality in patients with sepsis-associated encephalopathy: a study based on the medical information mart for intensive care database. BMC Infect Dis. 2025;25(1):858. https://doi.org/10.1186/s12879-025-11139-3.
